WAPNICK PAMELA (Chief Financial Officer) received a stock award from METAGENOMI THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/3/2025ACC: 0000950170-25-050103
Officer· Chief Financial Officer
Since Mar 2026
+98K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
98K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+14K
Price / share
—
Trade value
—
% of position
23.5%
4/1/2025
59.68K→73.68K
Total
Net shares
+14K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2025 | A · Award | +14K | — | — | 23.5% | 59.68K | 73.68K |
| Total | +14K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
84K shares
Shares
+84K
Strike price
1.32
Held after
84K
Exercisable
—
4/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock84K shares | 4/1/2025 | A · Award | +84K | 1.32 | — | 84K |